No Data
Synspective to Book 22.5 Million Yen in Subsidy Income in Q2
AIAI, GEI and others [Emerging Markets press release]
＜290A＞ Recorded a subsidy income of 0.022 billion yen as non-operating income. <4169> Recorded insurance income of 0.023 billion yen from Enchange as extraordinary profit. <5599> Acquisition of treasury stock for S&J has ended. <6190> PXB has revised its upward forecast for the previous term's operating loss to △0.142 billion yen from △0.253 billion yen, and decided to dissolve and liquidate its consolidated subsidiary KMT Hepatech, Inc. (Canada). <6557> AIAI has revised its upward forecast for the previous term's operating profit to 0.73 billion yen from 0.5 billion yen. <7343> Bro.
Growth 250 slightly declines, while Syns etc. rise = Emerging Markets, 24th.
The Tokyo Stock Exchange Growth Market 250 Index has slightly declined. Major stocks showed mixed performance, resulting in a lack of direction for the index. Space ventures such as Synspective <290A.T>, QPS Research <5595.T>, and Astroscale Holdings <186A.T> have risen. On the other hand, Sanbio <4592.T>, Trial <141A.T>, and Cover <5253.T> were sold off. The IPO (initial public offering) LIFE CREATE <352A.T> started with a modest increase.
Continued rise, excessive caution towards Trump's tariffs eases, and Buy back expands.
Overview for the week from April 14 to April 18: The Tokyo Stock Exchange Growth Index reached a high of 669.96 and a low of 626.62, closing at 669.96, with a week-on-week increase of 6.11% ↑. This continued rise was fueled by a decrease in excessive caution regarding Trump's tariffs, leading to a broadening of Buy-backs. Negotiations between Japan and the U.S. regarding the tariff policies of the Trump administration began, easing excessive caution. Compared to the previous week, where the Nikkei Average fluctuated with massive gains and losses of over 1,000 yen daily, the market showed signs of stability, prompting Buy-backs in Emerging Markets driven by perceived value.
Growth 250 continues to rise, with Sanbio and others increasing = Emerging Markets - October 18.
The Tokyo Stock Exchange Growth Market 250 Index continued to rise. A wide range of stocks experienced buying, resulting in a strong weekend market. SanBio <4592.T>, QPS Research Institute <5595.T>, and ABEJA <5574.T> saw increases. The rises of VRAIN Solution <135A.T> and Trite <9164.T> were also prominent. Synspective <290A.T> slightly declined. In the Standard Market, Universal Corp <6425.T> was bought.
Growth 250 rebounds, space ventures are STAR = Emerging Markets, 17th.
The TSE Growth Market 250 Index rebounded. Buying focused on major stocks resulted in a steady trend. Space ventures such as Synspective <290A.T>, ispace <9348.T>, and Astroscale Holdings <186A.T> are STAR. Plaid <4165.T> and Heartsseed <219A.T> also saw increases. Trial Holdings <141A.T> and AI Robotics <247A.T> are low. In the standard category.
